814
Views
23
CrossRef citations to date
0
Altmetric
Research Paper

ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6

& ORCID Icon
Pages 647-655 | Received 30 Oct 2019, Accepted 11 Mar 2020, Published online: 18 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Qiang Sun, Jinlong Gong, Xueyi Gong, Jianlong Wu, Zhipeng Hu, Qiao Zhang & Xiaofeng Zhu. (2022) Long non-coding RNA MALAT1 aggravated liver ischemia-reperfusion injury via targeting miR-150-5p/AZIN1. Bioengineered 13:5, pages 13422-13436.
Read now
Chuanli Zeng, Gang Yuan, Yaoren Hu, Donghui Wang, Xiaojun Shi, Dedong Zhu, Airong Hu, Yina Meng & Jialin Lu. (2022) Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma. Bioengineered 13:1, pages 1491-1506.
Read now
Junchuang He, Hongxian Yan, Sidong Wei & Guoyong Chen. (2021) LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis. OncoTargets and Therapy 14, pages 3209-3223.
Read now

Articles from other publishers (20)

Liya Hu, Hong Cao, Lijun Zheng & Ruichao Li. (2023) BBOX1-AS1 Activates Hedgehog Signaling Pathway to Facilitate the Proliferation and Stemness of Esophageal Squamous Cell Carcinoma Cells via miR-506-5p/EIF5A/PTCH1 Axis. Current Molecular Pharmacology 16:8.
Crossref
Qinyan Yang, Yuxin Liang, Ying Shi, Jin Shang & Xiaolun Huang. (2023) The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway. Journal of Cancer Research and Clinical Oncology 149:17, pages 15499-15510.
Crossref
Hanji Huang, Dejie Lu, Kanglu Li, Mingjun Zheng, Xiong Qin, Xiaofei Cui, Ying Chen, Chaotao Chen, Nanchang Huang, Li Zheng, Jinmin Zhao & Bo Zhu. (2023) Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6. Biochemical Pharmacology 214, pages 115667.
Crossref
Yan Wang, Hui Li, Wenbin Chen, Xiaoliang Huang, Renliang Fan, Meijia Xu & Li Zou. (2023) CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195-3p/HMGB3 network. General Thoracic and Cardiovascular Surgery.
Crossref
Xijuan Peng, Lanfu Zhao, Linong Yao, Jingzhi Dong, Wei Wu & Tao Luo. (2023) Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non‐small cell lung carcinoma . Thoracic Cancer 14:19, pages 1812-1823.
Crossref
Jiayi Wang, Xing Wu, Jiahao Xu, Yangjie Liao, Minzi Deng, Xiaoyan Wang & Jingbo Li. (2023) Differential expression and bioinformatics analysis of exosome circRNAs in pancreatic ductal adenocarcinoma. Translational Oncology 33, pages 101686.
Crossref
Nicola Mosca, Aniello Russo & Nicoletta Potenza. (2023) Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:10, pages 8886.
Crossref
Song Guo, Bingtan Song, Lin Li, Hesheng Li, Tao Yang, Lianmeng Cao & Jian Wang. (2023) lncRNA HCG11 Promotes Colorectal Cancer Cell Malignant Behaviors via Sponging miR-26b-5p. Journal of Immunology Research 2023, pages 1-16.
Crossref
Xing Zeng, Zhiquan Hu, Yuanqing Shen, Xian Wei, Jiahua Gan & Zheng Liu. (2022) MiR-5195-3p functions as a tumor suppressor in prostate cancer via targeting CCNL1. Cellular & Molecular Biology Letters 27:1.
Crossref
Yan Qiao, Bin Wang, Yu Yan & Ligang Niu. (2022) Long noncoding RNA ST8SIA6‐AS1 promotes cell proliferation and metastasis in triple‐negative breast cancer by targeting miR ‐145‐5p/ CDCA3 to inactivate the p53/p21 signaling pathway . Environmental Toxicology 37:10, pages 2398-2411.
Crossref
Zuowei Li, Chengcheng Zhang, Xin Zong, Zhao Wang, Rong Ren, Lei Wang, Ping Sun, Chunmei Zhu, Mingxia Guo, Guizhen Guo, Guo Hu & Ya’nan Wu. (2022) ST8SIA6-AS1 Promotes the Epithelial-to-Mesenchymal Transition and Angiogenesis of Pituitary Adenoma. Journal of Oncology 2022, pages 1-15.
Crossref
Omri Nayshool, Nitzan Kol, Elisheva Javaski, Ninette Amariglio & Gideon Rechavi. (2022) SurviveAI: Long Term Survival Prediction of Cancer Patients Based on Somatic RNA-Seq Expression. Cancer Informatics 21, pages 117693512211278.
Crossref
Yanjie Mou & Xiaoming Ding. (2022) LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p/TM4SF4 axis. Anti-Cancer Drugs Publish Ahead of Print.
Crossref
Peng Huang, Mengxiang Xu, Haijun Han, Xinyi Zhao, Ming D. Li & Zhongli Yang. (2021) Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Weichen Wang, Longlong Wang, Mengyue Yang, Chunwei Wu, Rui Lan, Weiwei Wang & Yuze Li. (2021) Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy. Cell Death & Disease 12:11.
Crossref
Yang Zhang, Yan Yang, Yi Zhang & Zhisu Liu. (2021) lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3p. Experimental and Therapeutic Medicine 22:6.
Crossref
Jinghua Kuai, Lijie Zheng, Xin Yi, Zengli Liu, Bo Qiu, Zhihua Lu & Yuanhui Jiang. (2021) ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis. Digestive and Liver Disease 53:9, pages 1192-1200.
Crossref
Di Wang, Xi Ming, Jinhuan Xu & Yi Xiao. (2021) Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR‐5195‐3p/GRB10 axis. Hematological Oncology 39:3, pages 390-400.
Crossref
Lei Yu, Wei Zhang, Peng Wang, Qi Zhang, Aihua Cong, Xiuyuan Yang & Kai Sang. (2021) LncRNA SNHG11 aggravates cell proliferation and migration in triple‑negative breast cancer via sponging miR‑2355‑5p and targeting CBX5. Experimental and Therapeutic Medicine 22:2.
Crossref
Zhanghan Chen, Jie Huang, Yanling Feng, Zehuan Li & Ying Jiang. (2021) Profiling of specific long non‐coding RNA signatures identifies ST8SIA6‐AS1 AS a novel target for breast cancer. The Journal of Gene Medicine 23:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.